EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity

Hyewon Cho, Eun Lee, Jisoo Kim, Soojeong Shin, Yoon-Jung Kim, Heejin Lee, Ji Hoon Yu, Yong Hyun Jeon, Sang Wu Lee, So Young Lee, Ki Whan Park, Jong Soon Kang und 3 weitere

European Journal of Pharmaceutical Sciences · 2024

DOI: 10.1016/j.ejps.2024.106921 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2024. Verfasst von Hyewon Cho und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Sookmyung Women's University, Cheongpa-ro 47-gil 100, Yongsan-gu, Seoul, 04310, Republic of Korea. Hauptthemen laut MEDLINE: Histone Deacetylases, Histone Deacetylase Inhibitors, Neuroblastoma, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, Ministry of Health and Welfare, Commercializations Promotion Agency for R&D Outcomes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone DeacetylasesHistone Deacetylase InhibitorsNeuroblastomaAntineoplastic AgentsAnimalsHumansCell Line, TumorStructure-Activity RelationshipMolecular Docking SimulationRepressor ProteinsCell ProliferationMiceMice, NudeXenograft Model Antitumor AssaysSulfur Compounds

Stichwörter der Autor:innen

Histone deacetylase 8InhibitorNeuroblastomaOrganosulfur

Substanzen

Histone DeacetylasesHistone Deacetylase InhibitorsHDAC8 protein, humanAntineoplastic AgentsRepressor ProteinsSulfur Compounds

Autor:innen und Institutionen

  • College of Pharmacy, Sookmyung Women's University, Cheongpa-ro 47-gil 100, Yongsan-gu, Seoul, 04310, Republic of Korea.
  • New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI hub), Daegu, Republic of Korea.
  • Preclincial Research Center (PRC), Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI hub), Daegu, Republic of Korea.
  • College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, 21983, Republic of Korea.
  • EONE-DIAGNOMICS New drug R&D Center, 708 MCC B Building, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul, Republic of Korea.
  • Laboratory Animal Resource and Research Center, Korea Research Institute of Bioscience and Biotechnology, 30 Yeongudanjiro, Ochang, Cheongwon, Cheongju, 28116, Republic of Korea.

Förderung

  • Ministry of Trade, Industry and Energy
  • Ministry of Health and Welfare
  • Commercializations Promotion Agency for R&D Outcomes
  • Korea Drug Development Fund
  • National Research Foundation of Korea

Zitieren

APA

Cho, H., Lee, E., Kim, J., Shin, S., Kim, Y. J., Lee, H., Yu, J. H., Jeon, Y. H., Lee, S. W., Lee, S. Y., Park, K. W., Kang, J. S., Kwon, S. H., Kim, Y., & Jeon, R. (2024). Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2024.106921

Vancouver

Cho H, Lee E, Kim J, Shin S, Kim YJ, Lee H, et al. Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity. European Journal of Pharmaceutical Sciences. 2024. doi:10.1016/j.ejps.2024.106921

BibTeX
@article{Cho2024,
  author = {Cho, Hyewon and Lee, Eun and Kim, Jisoo and Shin, Soojeong and Kim, Yoon-Jung and Lee, Heejin and Yu, Ji Hoon and Jeon, Yong Hyun and Lee, Sang Wu and Lee, So Young and Park, Ki Whan and Kang, Jong Soon and Kwon, So Hee and Kim, Yonjung and Jeon, Raok},
  title = {Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity},
  journal = {European Journal of Pharmaceutical Sciences},
  year = {2024},
  doi = {10.1016/j.ejps.2024.106921}
}
Kostenlos starten →